What you need to know

The Pharmaceutical Care Management Association (PCMA) issued a press release announcing a commitment related to prescription drug pricing transparency. The commitment is supported by member pharmacy benefit managers (PBMs), including Prime, and reflects an industry effort to help consumers better understand prescription drug pricing and advance future transparency solutions, where permitted by law and consistent with plan coverage. 

The announcement represents an industry pledge rather than a regulatory requirement and does not establish a mandated implementation timeline or require action from clients.

For Prime, it continues our commitment to support the broader goals of affordability and transparency while preserving client choice and allowing cost transparency tools to evolve over time.

Overview

In coordination with the Trump administration and the Centers for Medicare & Medicaid Services (CMS), PCMA will announce an industry commitment focused on greater prescription drug pricing transparency for consumers. The effort is intended to provide consumers with additional information about prescription drug pricing, including visibility into cash-pay options offered through TrumpRx. 

The commitment reflects a broader industry focus on helping consumers evaluate prescription drug costs and payment options when making purchasing decisions. While the announcement does not require changes to current benefit designs, it reflects continued interest in tools and solutions that help consumers make informed decisions about prescription drug costs. 

Prime's position

Our approach remains focused on balancing affordability, flexibility and simplicity. Prime supports efforts to help improve prescription drug affordability and transparency for clients and members, and offers a suite of affordability-focused products today honoring these commitments. 

This pledge recognizes evolving consumer needs and the importance of providing meaningful pricing information. Through ongoing product enhancements, we’ll continue to explore opportunities to simplify the pharmacy experience, support informed decision making and help clients provide members with greater visibility into medication cost options.